We are presenting our data at the DDR inhibitor summit,

We are happy to announce that on the 22nd of

We look forward to meeting you in person and sharing

Our team is happy and proud to have been voted

CEO Ana Slipicevic present the MTHFD2 program and one-carbon therapeutics

The MTHFD2 program is pitched by CEO Dr Ana Slipicevic

One-carbon therapeutics AB is granted 3,000,000 SEK from Sweden’s innovation agency

We are proud that the MTHFD2 inhibitors are now published

We are very pleased to announce that Dr Ana Slipicevic